There is evidence that both memory B cells and autoantibodies are formed both in secondary lymphoid organs and locally in the affected organ and in GCs as well as in extrafollicular aggregates. One of the most commonly used markers for autoimmune rheumatic diseases is rheumatoid factor (RF), an autoantibody directed against the Fc portion of IgG. Such autoantibodies are for instance present in lupus-prone MRL/lpr mice. These autoantibodies have undergone CSR and SHM, and the RF-specific B cell response is very similar to a memory B cell response
elicited by an exogenous antigen [50]. Using a model system, it has been shown that TG B cells with a BCR specific for RF (AM14) are activated in a T cell–dependent click here manner and that this takes place extrafollicularly at the border of the T cell zone and red pulp in the spleen, rather than in GCs. Similar to the Td memory B cells discussed above, the autoreactive AM 14 B cells can further develop into CD73-positive memory B cells, as well as into short-lived plasma cells [51-58]. The survival of B cells in GCs is dependent on a variety of factors, including the cell death receptor Fas. This receptor plays a role in the elimination of the non-specific and
autoreactive B cells in the GC; thus, find more if the Fas or FasL signalling pathway is disrupted, survival and generation of autoreactive memory B cells and plasma cells are allowed. By contrast, during the selection of antigen-specific non-autoreactive B cells, other escape signals ensure the resistance to Fas-mediated apoptosis [59]. Indeed, the SLE-like syndrome, including glomerulonephritis, polyarteritis, arthritis and sialoadenitis, that develop in MRL/lpr mice is due to a defective Fas gene (lpr) in combination with other (mainly unidentified) mutations [49, 60]. Spontaneous formation of GCs is known to ID-8 take place in secondary lymphoid organs of autoimmune
mice, such as spontaneously diabetic NOD mice and lupus models (MRL/lpr, PN, NZB, NZB/W, B6/lpr and BXSB male mice), already at one to 2 months of age in the absence of immunization or infection. Both the GCs that develop in autoimmunity and those caused by immunization are T cell–dependent, based on the abrogation of GCs after treatment with anti-CD40 ligand antibodies. Spontaneous formation of GCs in the autoimmune setting is also known to take place in the affected organs, for example, in the pancreatic islets of diabetic NOD mice and in the synovial tissue in collagen-induced arthritis, the most commonly used mouse model for RA. In diabetic NOD mice, the islets’ GCs closely resemble those in secondary lymphoid organs in that they contain FDCs and T cells, the B cells upregulate AID and express a somatically mutated oligoclonal BCR repertoire [61]. Further, the GC B cells can differentiate in situ to plasma cells, producing antibodies directed against insulin, and most likely also memory B cells [62].
Related posts:
- Genes linked to figuring out and memory Some of the ICSS upregul
- CFSElow and CFSEhigh B cells were
- Aloe-emodin of IgM and IgG in Kulturberst Walls and the number of B cells
- protein content of cells When lysed cells were diluted and analy
- Also, there is certainly evidence that aberrant Toll like recep t